Maria Jose Soler Spain

MD, PhD. Head of Clinical Nephrology and Dialysis Unit Nephrology Department. Hospital Universitari Vall d´Hebron. Research lab group leader, Vall d'Hebron Research Institute (VHIR). Vice-presidente Junta Directiva Sociedad Española Nefrología. Co-Chair of the ISN Western Europe Regional Board.

28 March 2026

Time	Session

8:30 a.m. 10 a.m.	Onco-Nephrology Course: Acute Kidney Injury (AKI) in the Cancer Patient KenarJhaveri Moderator United States Maria JoseSoler Moderator Spain SabineKaram Moderator United States AKI Due to Chemotherapy Diana CarolinaVargas Angel Speaker Colombia AKI Due to Targeted Therapy MotokoYanagita Speaker Japan AKI Due to Immunotherapy Maria JoseSoler Speaker Spain Roundtable Discussion KenarJhaveri Moderator United States 304
10:30 a.m. 12 p.m.	Onco-Nephrology Course: Electrolyte Disturbances in the Cancer Patient KenarJhaveri Moderator United States Maria JoseSoler Moderator Spain SabineKaram Moderator United States Hyponatremia in Patients with Cancer SanjeevNair Speaker India Hypercalcemia in Patients with Cancer MohamedHassanein Speaker Egypt Hypomagnesemia and Hypophosphatemia in Patients With Cancer JolantaMalyszko Speaker Poland Roundtable Discussion KenarJhaveri Moderator United States 304
12:15 p.m. 1:15 p.m.	Onco-Nephrology Course: Onco-Nephrology in Special Populations KenarJhaveri Moderator United States Maria JoseSoler Moderator Spain SabineKaram Moderator United States Onco-nephrology in the Kidney Transplant Population RobertCarroll Speaker robert.carroll@health.sa.gov.auAustralia Onco-Hypertension: Mechanisms, Monitoring, and Management SabineKaram Speaker United States GFR Estimation in Patients With Cancer ShuchiAnand Speaker sanand3@health.ucdavis.eduUnited States Q&A and Final Remarks KenarJhaveri Moderator United States 304

29 March 2026

Time	Session

12:50 p.m. 1:50 p.m.	Industry Symposium 16 MotokoYanagita Moderator Japan Welcome & Introduction MotokoYanagita Speaker Japan Orchestrating Excellence: KDIGO’s Guidance on the Management of IgA Nephropathy Sydney Tang Speaker Hong Kong, China Setting the Tempo: The Importance of Early Diagnosis and Treatment in IgA Nephropathy Maria JoseSoler Speaker Spain A Harmonious Approach: Simultaneously Targeting Both Drivers VladoPerkovic Speaker Australia A Note of Hope: Reimagining the Outcomes for Patients With IgA Nephropathy MotokoYanagita Speaker Japan Summary & Close MotokoYanagita Speaker Japan 503

Time

Session

12:50 p.m.

1:50 p.m.

Industry Symposium 16

MotokoYanagita Moderator Japan

Welcome & Introduction

MotokoYanagita Speaker Japan
Orchestrating Excellence: KDIGO’s Guidance on the Management of IgA Nephropathy

Sydney Tang Speaker Hong Kong, China
Setting the Tempo: The Importance of Early Diagnosis and Treatment in IgA Nephropathy

Maria JoseSoler Speaker Spain
A Harmonious Approach: Simultaneously Targeting Both Drivers

VladoPerkovic Speaker Australia
A Note of Hope: Reimagining the Outcomes for Patients With IgA Nephropathy

MotokoYanagita Speaker Japan
Summary & Close

MotokoYanagita Speaker Japan

503

30 March 2026

Time	Session

2:10 p.m. 3:10 p.m.	Onco-nephrology: Navigating the Complexities of Kidney Disease in Patients With Cancer IK AnuragSingh Moderator Canada BhavnaBhasin-Chhabra Moderator United States Cancer Screening in Kidney Transplant Recipients and Dialysis Patients Chi Yuen SimonCheung Speaker Hong Kong, China Chronic Kidney Disease After Childhood Cancer Maria JoseSoler Speaker Spain Roundtable Discussion 301 - 302